Binxian Wei - 06 Oct 2025 Form 4/A - Amendment Insider Report for PALISADE BIO, INC. (PALI)

Role: Director
Signature: /s/ Ryker Willie, Attorney-in-Fact
Issuer symbol: PALI
Transactions as of: 06 Oct 2025
Net transactions value: $0
Form type: 4/A - Amendment
Filing time: 06 Nov 2025, 20:20:11 UTC
Date Of Original Report: 08 Oct 2025
Previous filing: 05 Sep 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Wei Binxian	Director	1902 WRIGHT PLACE, SUITE 200, CARLSBAD	/s/ Ryker Willie, Attorney-in-Fact	06 Nov 2025	0001773586

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PALI	Restricted Stock Units	Award	$0	+60,600		$0.000000	60,600	06 Oct 2025	Common Stock	60,600		Direct	F1, F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock, provided that, until such time as the Issuer has sufficient shares of Issuer common stock reserved under its 2021 Equity Incentive Plan (the "Plan") to issue upon settlement of all outstanding grants thereunder, the RSUs may be settled upon vesting in cash.
F2	This amended Form 4 is being filed to correct the previously reported grant amount of 510,700 RSUs to the Reporting Person. The Issuer has rescinded the grant of 450,100 RSUs of the previously reported grant of 510,700 RSUs.
F3	The RSUs are subject to a service-based vesting requirement and shall vest in three equal annual installments, with the first installment vesting on the earlier of (i) the date of the 2026 annual meeting of stockholders or (ii) the anniversary of October 6, 2025, subject to the Reporting Person's continuous service with the Issuer through such date.